GB1524180A - Antibacterial compositions - Google Patents

Antibacterial compositions

Info

Publication number
GB1524180A
GB1524180A GB24737/77A GB2473777A GB1524180A GB 1524180 A GB1524180 A GB 1524180A GB 24737/77 A GB24737/77 A GB 24737/77A GB 2473777 A GB2473777 A GB 2473777A GB 1524180 A GB1524180 A GB 1524180A
Authority
GB
United Kingdom
Prior art keywords
antibacterial compositions
june
salt
compositions
anitbiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24737/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of GB1524180A publication Critical patent/GB1524180A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB24737/77A 1976-06-18 1977-06-14 Antibacterial compositions Expired GB1524180A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51072458A JPS6049602B2 (ja) 1976-06-18 1976-06-18 抗菌剤

Publications (1)

Publication Number Publication Date
GB1524180A true GB1524180A (en) 1978-09-06

Family

ID=13489871

Family Applications (1)

Application Number Title Priority Date Filing Date
GB24737/77A Expired GB1524180A (en) 1976-06-18 1977-06-14 Antibacterial compositions

Country Status (8)

Country Link
US (1) US4092411A (nl)
JP (1) JPS6049602B2 (nl)
AU (1) AU512893B2 (nl)
BE (1) BE855766A (nl)
DE (1) DE2727247A1 (nl)
FR (1) FR2354768A1 (nl)
GB (1) GB1524180A (nl)
NL (1) NL7706461A (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196193A (en) * 1978-02-15 1980-04-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US20050009931A1 (en) * 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923977A (en) * 1972-08-29 1975-12-02 Fujisawa Pharmaceutical Co Antibiotic FR-1923 substance

Also Published As

Publication number Publication date
AU2620677A (en) 1978-12-21
NL7706461A (nl) 1977-12-20
DE2727247A1 (de) 1977-12-29
AU512893B2 (en) 1980-11-06
JPS6049602B2 (ja) 1985-11-02
US4092411A (en) 1978-05-30
FR2354768A1 (fr) 1978-01-13
FR2354768B1 (nl) 1981-01-09
BE855766A (fr) 1977-12-16
JPS52156931A (en) 1977-12-27

Similar Documents

Publication Publication Date Title
ES2000602A6 (es) Procedimiento para la preparacion de nuevos peptidos relacionados con la calcitonina
AU519861B2 (en) Antibacterial oral composition
IE782546L (en) Amino-thiazolyl cephalosporins
YU54189A (en) Process for obtaining cephem derivatives and midproducts for the same
GB1461032A (en) Erthromycylamine derivatives
AU2738477A (en) Antibacterial oral composition
MY8500128A (en) New cephalosporin derivatives, their production and use as antimicrobial agents
ES472284A1 (es) Procedimiento para la preparacion de 6-deoxineamina
IE781568L (en) Cyclopeptide antibiotic
GB1524180A (en) Antibacterial compositions
AU511643B2 (en) Preparation of 3, 4-dihydro-2-methyl-4-oxo-2h-1, 2-benzothiazine-3-carboxylic acid-1, 1-dioxide
AU520208B2 (en) Antibacterial oral composition
IE41899L (en) 7ó-methoxycephalosporins.
ES8205214A1 (es) Un procedimiento para la preparacion de un derivado de 3-o- desmetilsannamicina c o del antibiotico ax-127b-1.
GB1458340A (en) Ixo
GB1388178A (en) Benzylpyrimidine derivatives
ES465322A1 (es) Un procedimiento para preparar compuestos e imericos de 4"- amino.
AU4243078A (en) 2'-n-acyl and alkyl-6'-n-alkyl and 6', 6'-di-n-alkyl derivatives of fortimicins a & b
AU520488B2 (en) Phosphanilic acid and trimethoprim antibacterial compositions
IE38063L (en) Antibiotic g-52
IE790004L (en) Oleandomycins
GB1440850A (en) Vaso-regulator compositions
IE41466L (en) 2, 4-dioxo-1-pyrimidinylcephalosporin derivatives
AU6024880A (en) Antibiotic bm123 pamoate salt
ES8701182A1 (es) Un procedimiento para preparar sal monosodica del acido 7-d-mandelamido-3-(1-sulfometiltetrazol-5-il)tiometil-3-cefem-4-carboxilico

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee